Health
Therapeutic PD-1 cancer vaccine shown to be safe and effective in animal study: First-in-human clinical trial will test vaccine in select cancer patients – Science Daily
A study has described a potential therapeutic anticancer vaccine that frees suppressed cancer-killing immune cells, enabling them to attack and destroy a tumor.
A study led by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) described a potential therapeutic anticancer vaccine that frees suppressed cancer-killing immune cells, enabling them to attack and destroy a tumor.Published in the journal Oncoimmunology, on October 1, 2020, the findings showed that the peptide called PD1-Vaxx, a first checkpoint inhibitor vaccine, was safe and effective…
-
Noosa News15 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
Business24 hours agoRevenue growth, profit margin pressures, and a $365m buyback
-
Noosa News23 hours agoNT cattle rustler fined almost $430k for stealing 116 head from neighbouring station
-
Noosa News23 hours agoThe wait to taste new Queensland-grown purple-skinned pineapples